Publications


Identification of apilimod as a first-in-class PIKfyve kinase inhibitor for treatment of B-cell non-Hodgkin lymphoma

Sophia Gayle, Sean Landrette, Neil Beeharry, Chris Conrad, Marylens Hernandez, Paul Beckett, Shawn M. Ferguson, Talya Mandelkern, Meiling Zheng, Tian Xu, Jonathan Rothberg and Henri Lichenstein
Blood 2017 129:1768-1778; doi: https://doi.org/10.1182/blood-2016-09-736892

View publication (PDF, 1.8 MB)

View supplemental methods, figures, and data (PDF, 1.9 MB)

B-cell non-Hodgkin lymphoma: Selective vulnerability to PIKFYVE inhibition

Sophia Gayle, Sean Landrette, Neil Beeharry, Chris Conrad, Marylens Hernandez, Paul Beckett, Shawn M. Ferguson, Talya Mandelkern, Meiling Zheng, Tian Xu, Jonathan Rothberg and Henri Lichenstein
Autophagy 2017, VOL. 13, NO. 6, 1–2; http://dx.doi.org/10.1080/15548627.2017.1304871

View publication (PDF, 80 KB)

Toward autophagy-targeted therapy in lymphoma

Lapo Alinari
Blood 2017 129:1740-1742; doi: https://doi.org/10.1182/blood-2017-02-764639

View publication (PDF, 1.0 MB)